The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 0.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
SBI Mutual Fund, through its various schemes, purchased 22,40,000 shares of Privi Speciality Chemicals Ltd on December 31, 2025 via market purchase. This acquisition represents 5.7344% of the company's paid-up share capital and triggers a Regulation 29(1) disclosure under SEBI's Takeover Regulations. Prior to this purchase, SBI MF held 14,22,721 shares (3.6421%); after the acquisition, its total holding rose to 36,62,721 shares, or 9.3765% of the paid-up capital. The acquirer is not part of the promoter/promoter group, confirming this is institutional (FII/mutual fund) buying. The next regulatory trigger under SAST would be crossing the 10% threshold, which the fund is now approaching.
Positive sentiment signal — a marquee institutional investor (SBI MF) has significantly increased its stake, nearly doubling its holding in a single transaction. This suggests confidence in the company's prospects, but shareholders should note the fund is now just below the 10% SAST threshold, so further buying could attract additional regulatory scrutiny.